VS TR 2x Long VIX Futures ETF

ProShares Ultra VIX Short-Term Futures

Direxion Daily Semicondct Bear 3X ETF

United States Oil Fund

Direxion Dly S&P Oil&Gs Ex&Prd Bl 3X ETF

Direxion Financial Bear 3X Shar

Direxion Daily Small Cap Bear 3X ETF

Bank Of Montreal

MicroSectors Gold Miners 3X Leveraged ETN

Direxion Technology Bear 3X Shares

Direxion Daily Semicondct Bull 3X ETF

VS TR -1x Short VIX Futures ETF

Direxion Daily Financial Bull 3X ETF

Direxion Daily Small Cap Bull 3X ETF

ProShares UltraPro Dow30

Direxion Dly S&P Oil&Gs Ex&Prd Br 3X ETF

Direxion Daily Technology Bull 3X ETF

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

ProShares UltraShort Bloomberg Natrl Gas

AgEagle Aerial Systems Inc. Common Stock

Civitas Resources Inc. Common Stock

Oracle Corporation Common Stock

Halliburton Company Common Stock

Bunge Limited Bunge Limited

Occidental Petroleum Corporation Common Stock

CVR Energy Inc. Common Stock

Raytheon Technologies Corporation Common Stock

Whirlpool Corporation Common Stock

Permian Resources Corporation Class A Common Stock

Archer Aviation Inc. Class A Common Stock

Carvana Co. Class A Common Stock

ChargePoint Holdings Inc. Common Stock

Magna International Inc. Common Stock

Unity Software Inc. Common Stock

XPeng Inc. American depositary shares each representing two Class A ordinary shares

MGM Resorts International Common Stock

JELD-WEN Holding Inc. Common Stock

Granite Point Mortgage Trust Inc. Common Stock

Carnival Corporation Common Stock

Click here to get full coverage on We Found A Hidden Teva Sale Full Of Sandals At Up To 40% Off - Forbes

We Found A Hidden Teva Sale Full Of Sandals At Up To 40% Off  Forbes

We Found A Hidden Teva Sale Full Of Sandals At Up To 40% Off - Forbes

Click here to get full coverage on Americares, HDA honor Teva with Power of Partnership Award - Drug Store News

Americares, HDA honor Teva with Power of Partnership Award  Drug Store News

Americares, HDA honor Teva with Power of Partnership Award - Drug Store News

Click here to get full coverage on Zacks Industry Outlook Highlights Sandoz, Teva Pharmaceuticals and Viatris - Yahoo Finance

Zacks Industry Outlook Highlights Sandoz, Teva Pharmaceuticals and Viatris  Yahoo Finance

Zacks Industry Outlook Highlights Sandoz, Teva Pharmaceuticals and Viatris - Yahoo Finance

Click here to get full coverage on SG Americas Securities LLC Has $5.19 Million Stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA) - MarketBeat

SG Americas Securities LLC Has $5.19 Million Stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA)  MarketBeat

SG Americas Securities LLC Has $5.19 Million Stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA) - MarketBeat

Click here to get full coverage on Teva’s Next-Gen Trail Running Sandal Is Not Only Lighter — It’s Cheaper Too - Gear Patrol

Teva’s Next-Gen Trail Running Sandal Is Not Only Lighter — It’s Cheaper Too  Gear Patrol

Teva’s Next-Gen Trail Running Sandal Is Not Only Lighter — It’s Cheaper Too - Gear Patrol

Click here to get full coverage on The 5 Best Sandals for Men - GearLab

The 5 Best Sandals for Men - GearLab

Click here to get full coverage on Teva Pharmaceutical Industries To Present At Goldman Sachs Conference; Webcast At 8:00 AM ET - Nasdaq

Teva Pharmaceutical Industries To Present At Goldman Sachs Conference; Webcast At 8:00 AM ET  Nasdaq

Teva Pharmaceutical Industries To Present At Goldman Sachs Conference; Webcast At 8:00 AM ET - Nasdaq

Click here to get full coverage on FDA Grants Fast Track Designation to Teva’s TEV-53408 for Celiac Disease Treatment - geneonline.com

FDA Grants Fast Track Designation to Teva’s TEV-53408 for Celiac Disease Treatment  geneonline.com

FDA Grants Fast Track Designation to Teva’s TEV-53408 for Celiac Disease Treatment - geneonline.com

Click here to get full coverage on Teva at Goldman Sachs Conference: Strategic Shift to Biopharma - Investing.com

Teva at Goldman Sachs Conference: Strategic Shift to Biopharma  Investing.com

Teva at Goldman Sachs Conference: Strategic Shift to Biopharma - Investing.com

Click here to get full coverage on (TEVA) Trading Report - news.stocktradersdaily.com

(TEVA) Trading Report  news.stocktradersdaily.com

(TEVA) Trading Report - news.stocktradersdaily.com

Click here to get full coverage on Teva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026-2031 - GlobeNewswire

Teva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026-2031  GlobeNewswire

Teva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026-2031 - GlobeNewswire

Click here to get full coverage on I Field-Tested the Best Hiking Sandals. Here Are My Top Picks Built for Adventure - Men's Journal

I Field-Tested the Best Hiking Sandals. Here Are My Top Picks Built for Adventure  Men's Journal

I Field-Tested the Best Hiking Sandals. Here Are My Top Picks Built for Adventure - Men's Journal

Click here to get full coverage on I Hiked the Alps in Comfy Teva Sandals—and Now I’m Eyeing These 12 Similar Pairs, From $30 - Travel + Leisure

I Hiked the Alps in Comfy Teva Sandals—and Now I’m Eyeing These 12 Similar Pairs, From $30  Travel + Leisure

I Hiked the Alps in Comfy Teva Sandals—and Now I’m Eyeing These 12 Similar Pairs, From $30 - Travel + Leisure

Click here to get full coverage on Teva’s Layoffs Signal Deeper Fault Lines In The Pharmaceutical Business Model - Forbes

Teva’s Layoffs Signal Deeper Fault Lines In The Pharmaceutical Business Model  Forbes

Teva’s Layoffs Signal Deeper Fault Lines In The Pharmaceutical Business Model - Forbes

Click here to get full coverage on The 9 Best Sandals of 2025 - GearLab

The 9 Best Sandals of 2025 - GearLab

Click here to get full coverage on TEVA Stock Up Around 13% in a Month: Buy, Sell or Hold the Stock? - Yahoo Finance

TEVA Stock Up Around 13% in a Month: Buy, Sell or Hold the Stock?  Yahoo Finance

TEVA Stock Up Around 13% in a Month: Buy, Sell or Hold the Stock? - Yahoo Finance

Click here to get full coverage on Teva Pharmaceutical Industries Limited (NYSE:TEVA) Holdings Lifted by Duquesne Family Office LLC - MarketBeat

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Holdings Lifted by Duquesne Family Office LLC  MarketBeat

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Holdings Lifted by Duquesne Family Office LLC - MarketBeat

Click here to get full coverage on FDA Grants Fast Track Status to Teva’s TEV-53408 for Celiac Disease Treatment - geneonline.com

FDA Grants Fast Track Status to Teva’s TEV-53408 for Celiac Disease Treatment  geneonline.com

FDA Grants Fast Track Status to Teva’s TEV-53408 for Celiac Disease Treatment - geneonline.com

Click here to get full coverage on Greenwood Capital Associates LLC Boosts Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA) - MarketBeat

Greenwood Capital Associates LLC Boosts Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)  MarketBeat

Greenwood Capital Associates LLC Boosts Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA) - MarketBeat

Click here to get full coverage on Assenagon Asset Management S.A. Has $91.97 Million Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA) - MarketBeat

Assenagon Asset Management S.A. Has $91.97 Million Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)  MarketBeat

Assenagon Asset Management S.A. Has $91.97 Million Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA) - MarketBeat

Click here to get full coverage on Teva Announces Increase of the Maximum Tender Amount of its - GlobeNewswire

Teva Announces Increase of the Maximum Tender Amount of its  GlobeNewswire

Teva Announces Increase of the Maximum Tender Amount of its - GlobeNewswire

Click here to get full coverage on Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025 - GlobeNewswire

Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025  GlobeNewswire

Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025 - GlobeNewswire

Click here to get full coverage on Teva and Biolojic Design Initiate IND-enabling Studies of - GlobeNewswire

Teva and Biolojic Design Initiate IND-enabling Studies of  GlobeNewswire

Teva and Biolojic Design Initiate IND-enabling Studies of - GlobeNewswire

Click here to get full coverage on These $42 Sandals Are Olsen-Approved and Perfect for Long Walks - ELLE

These $42 Sandals Are Olsen-Approved and Perfect for Long Walks  ELLE

These $42 Sandals Are Olsen-Approved and Perfect for Long Walks - ELLE

Click here to get full coverage on Teva Announces Pricing and Early Acceptance Results of its Debt Tender Offer - GlobeNewswire

Teva Announces Pricing and Early Acceptance Results of its Debt Tender Offer  GlobeNewswire

Teva Announces Pricing and Early Acceptance Results of its Debt Tender Offer - GlobeNewswire

Click here to get full coverage on Teva Announces Launch of $2,000,000,000 (Equivalent) Offering of Senior Notes - GlobeNewswire

Teva Announces Launch of $2,000,000,000 (Equivalent) Offering of Senior Notes  GlobeNewswire

Teva Announces Launch of $2,000,000,000 (Equivalent) Offering of Senior Notes - GlobeNewswire

Click here to get full coverage on Fitch Ratings Agency Upgrades Teva Rating to BB+ Recognizing Successful Execution of Its Pivot to Growth Strategy - GlobeNewswire

Fitch Ratings Agency Upgrades Teva Rating to BB+ Recognizing Successful Execution of Its Pivot to Growth Strategy  GlobeNewswire

Fitch Ratings Agency Upgrades Teva Rating to BB+ Recognizing Successful Execution of Its Pivot to Growth Strategy - GlobeNewswire

Click here to get full coverage on Baker McKenzie advises on US$2.3 billion bond offering for Teva Pharmaceutical and concurrent tender offer - Baker McKenzie

Baker McKenzie advises on US$2.3 billion bond offering for Teva Pharmaceutical and concurrent tender offer  Baker McKenzie

Baker McKenzie advises on US$2.3 billion bond offering for Teva Pharmaceutical and concurrent tender offer - Baker McKenzie

Click here to get full coverage on As Austedo, Ajovy and Uzedy gain steam, Teva banks on $5B-plus in 2030 innovative drug sales - Fierce Pharma

As Austedo, Ajovy and Uzedy gain steam, Teva banks on $5B-plus in 2030 innovative drug sales  Fierce Pharma

As Austedo, Ajovy and Uzedy gain steam, Teva banks on $5B-plus in 2030 innovative drug sales - Fierce Pharma

Click here to get full coverage on Teva to cut nearly 3000 jobs as shift from pure-play generics picks up pace - FirstWord Pharma

Teva to cut nearly 3000 jobs as shift from pure-play generics picks up pace  FirstWord Pharma

Teva to cut nearly 3000 jobs as shift from pure-play generics picks up pace - FirstWord Pharma

Click here to get full coverage on European Commission Fines Teva €462.6 Million - McDermott Will & Emery

European Commission Fines Teva €462.6 Million  McDermott Will & Emery

European Commission Fines Teva €462.6 Million - McDermott Will & Emery

Click here to get full coverage on I Bought These $42 Sandals Because of the Olsen Twins, and I Can't Believe How Expensive They Look - Who What Wear

I Bought These $42 Sandals Because of the Olsen Twins, and I Can't Believe How Expensive They Look  Who What Wear

I Bought These $42 Sandals Because of the Olsen Twins, and I Can't Believe How Expensive They Look - Who What Wear

Click here to get full coverage on Why Investors Should Watch Teva Despite Regional Risks (NYSE:TEVA) - Seeking Alpha

Why Investors Should Watch Teva Despite Regional Risks (NYSE:TEVA)  Seeking Alpha

Why Investors Should Watch Teva Despite Regional Risks (NYSE:TEVA) - Seeking Alpha

Click here to get full coverage on Teva Announces Early Tender Results of its Debt Tender - GlobeNewswire

Teva Announces Early Tender Results of its Debt Tender  GlobeNewswire

Teva Announces Early Tender Results of its Debt Tender - GlobeNewswire

Click here to get full coverage on Teva Pharmaceutical Industries (NYSE:TEVA) Upsizes Senior Notes Offering to US$2.3 Billion - Yahoo Finance

Teva Pharmaceutical Industries (NYSE:TEVA) Upsizes Senior Notes Offering to US$2.3 Billion  Yahoo Finance

Teva Pharmaceutical Industries (NYSE:TEVA) Upsizes Senior Notes Offering to US$2.3 Billion - Yahoo Finance

Click here to get full coverage on Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA - GlobeNewswire

Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA  GlobeNewswire

Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA - GlobeNewswire

Click here to get full coverage on Teva plots thousands of job cuts as restructuring drive enters 'acceleration' phase - Fierce Pharma

Teva plots thousands of job cuts as restructuring drive enters 'acceleration' phase  Fierce Pharma

Teva plots thousands of job cuts as restructuring drive enters 'acceleration' phase - Fierce Pharma

Click here to get full coverage on Teva to Host Innovation & Strategy Day on Thursday, May 29 in New York City - GlobeNewswire

Teva to Host Innovation & Strategy Day on Thursday, May 29 in New York City  GlobeNewswire

Teva to Host Innovation & Strategy Day on Thursday, May 29 in New York City - GlobeNewswire

Click here to get full coverage on Teva Reaffirms “Pivot to Growth” Strategy Progress with Launch of Acceleration Phase at 2025 Innovation and Strategy Day - Yahoo Finance

Teva Reaffirms “Pivot to Growth” Strategy Progress with Launch of Acceleration Phase at 2025 Innovation and Strategy Day  Yahoo Finance

Teva Reaffirms “Pivot to Growth” Strategy Progress with Launch of Acceleration Phase at 2025 Innovation and Strategy Day - Yahoo Finance

Click here to get full coverage on Teva Pharmaceutical Industries Limited (NYSE:TEVA) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Receives Consensus Rating of "Buy" from Analysts  MarketBeat

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Click here to get full coverage on Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention - GlobeNewswire

Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention  GlobeNewswire

Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention - GlobeNewswire

Click here to get full coverage on Why Is Teva Stock Trading Higher On Tuesday? - Yahoo Finance

Why Is Teva Stock Trading Higher On Tuesday?  Yahoo Finance

Why Is Teva Stock Trading Higher On Tuesday? - Yahoo Finance

Click here to get full coverage on Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory - Yahoo Finance

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory  Yahoo Finance

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory - Yahoo Finance

Click here to get full coverage on New Data from Teva Shows Substantial Rates of Undertreated - GlobeNewswire

New Data from Teva Shows Substantial Rates of Undertreated  GlobeNewswire

New Data from Teva Shows Substantial Rates of Undertreated - GlobeNewswire

Click here to get full coverage on Teva Mush II Review - GearLab

Teva Mush II Review - GearLab

Click here to get full coverage on Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June - GlobeNewswire

Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June  GlobeNewswire

Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June - GlobeNewswire

Click here to get full coverage on Lilly, J&J, Pfizer and Sanofi back Teva fight against IRA drug negotiation program - Fierce Pharma

Lilly, J&J, Pfizer and Sanofi back Teva fight against IRA drug negotiation program  Fierce Pharma

Lilly, J&J, Pfizer and Sanofi back Teva fight against IRA drug negotiation program - Fierce Pharma

Click here to get full coverage on Why Teva Pharmaceuticals Stock Blasted 6% Higher Today - The Motley Fool

Why Teva Pharmaceuticals Stock Blasted 6% Higher Today  The Motley Fool

Why Teva Pharmaceuticals Stock Blasted 6% Higher Today - The Motley Fool

Click here to get full coverage on These Comfortable Olsen-Approved Sandals Are a Timeless Summer Buy - Vogue

These Comfortable Olsen-Approved Sandals Are a Timeless Summer Buy  Vogue

These Comfortable Olsen-Approved Sandals Are a Timeless Summer Buy - Vogue

Click here to get full coverage on Teva’s 2024 Healthy Future Report Highlights Sustainability - GlobeNewswire

Teva’s 2024 Healthy Future Report Highlights Sustainability  GlobeNewswire

Teva’s 2024 Healthy Future Report Highlights Sustainability - GlobeNewswire

Click here to get full coverage on Teva Pharmaceutical's branded drugs boost first quarter profit - Reuters

Teva Pharmaceutical's branded drugs boost first quarter profit  Reuters

Teva Pharmaceutical's branded drugs boost first quarter profit - Reuters

Click here to get full coverage on Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidenc - GlobeNewswire

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidenc  GlobeNewswire

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidenc - GlobeNewswire

Click here to get full coverage on Teva debuts global campaign encouraging people to get outside - Retail Dive

Teva debuts global campaign encouraging people to get outside  Retail Dive

Teva debuts global campaign encouraging people to get outside - Retail Dive

Click here to get full coverage on Teva's Massive $2.3 Billion Debt Tender Results: Key Details From Early Acceptance Round - Stock Titan

Teva's Massive $2.3 Billion Debt Tender Results: Key Details From Early Acceptance Round  Stock Titan

Teva's Massive $2.3 Billion Debt Tender Results: Key Details From Early Acceptance Round - Stock Titan

Click here to get full coverage on Teva files lawsuit against drug-price negotiations - Healthcare Finance News

Teva files lawsuit against drug-price negotiations  Healthcare Finance News

Teva Pharma Industries Ltd ADR (TEVA)

Price Chart

Key Statistics

Technicals

About TEVA

Latest News

We Found A Hidden Teva Sale Full Of Sandals At Up To 40% Off - Forbes

Americares, HDA honor Teva with Power of Partnership Award - Drug Store News

Zacks Industry Outlook Highlights Sandoz, Teva Pharmaceuticals and Viatris - Yahoo Finance

Environment, Social and Governance (ESG) Risk Ratings

Controversy Level

Advanced Charts

Top Gainers

Top Losers